James Scopa, J.D., M.B.A.
James Scopa, J.D., M.B.A. joined Adverum’s board in May 2019. He brings over 30 years of experience in the life sciences industry, investing in companies and advising public and private boards on strategic and financial transactions. He most recently was a managing director and member of the investment committee of MPM Capital, a global life sciences venture capital firm. Prior to MPM, Mr. Scopa spent 18 years advising growth companies in biopharmaceuticals and medical devices principally at Deutsche Banc Alex Brown and Thomas Weisel Partners. Mr. Scopa currently serves on the board of directors of Blade Therapeutics as chair of its audit committee and on its compensation committee, as well as the advisory board and the investment advisory committee of One Ventures. Mr. Scopa received an A.B. from Harvard College, an M.B.A. from Harvard Business School, and a J.D. from Harvard Law School.